Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/12183
Title: Total pancreatectomy for the treatment of pancreatic neoplasms.
Authors: Nikfarjam, Mehrdad;Low, Nicholas;Weinberg, Laurence;Chia, Ping Han;He, Hong;Christophi, Christopher
Affiliation: Department of Surgery, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.
Issue Date: 22-Apr-2014
Citation: Anz Journal of Surgery 2014; 84(11): 823-6
Abstract: Total pancreatectomy (TP) is an operation that has long been associated with high morbidity and mortality, and rarely advocated for treatment of pancreatic tumours. Because of the improvements in diabetes management, there has been renewed interest in TP for treatment of pancreatic neoplasm, with a need to reassess outcomes.Fifteen patients (9%) underwent TP in a single Australian high-volume tertiary institution between August 2005 and January 2012. Pancreaticoduodenectomy (PD) was performed in 150 patients during the same time period. Indications and peri-operative outcomes of patients were compared.TP was performed for treatment of malignancy in 13 (87%) cases, for tumours involving the pancreatic neck. Complete tumour clearance achieved. Portal vein resections were more frequently required than in the PD group (5 (33%) versus 9 (6%); P = 0.004), as were blood transfusions (11 (73%) versus 28 (19%); P < 0.001), and median operative times were longer (10.5 versus 7.0 h; P < 0.001). Overall, complications were significantly greater in the TP group compared with the PD group (13 (87%) versus 86 (57%); P = 0.029), but the difference was mainly as a result of high grade I complications, in particular symptomatic hypoglycaemia (4 (27%) versus 0 (0%): P < 0.001) that could be easily managed. The overall lengths of stay and readmission rates were similar between groups.TP should be considered in selective cases for treatment of pancreatic neoplasm if it allows complete clearance. The procedure does not appear to be associated with significant increases in serious complications compared with PD.
Internal ID Number: 24754229
URI: http://ahro.austin.org.au/austinjspui/handle/1/12183
DOI: 10.1111/ans.12640
URL: http://www.ncbi.nlm.nih.gov/pubmed/24754229
Type: Journal Article
Subjects: adenocarcinoma
intraductal papillary mucinous neoplasm
pancreatic neck
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.